SUS CLINICALS
By: SUS CLINICALS, INC.
associated with 2 other trademarks
Clinical and laboratory research and testing, research testing of materials, namely, the use of genetically-engineered pigs, into which an adenoviral ...

Words that describe this trademark:

clinical laboratory research  testing testing  research testing  laboratory research  testing materials  testing protocols  materials testing  development cancer  used  protocols 

Serial Number:

90881874

Mark:

SUS CLINICALS

Status:

Registered

Status Date:

03-28-2023

Filing Date:

Registration Number:

7009210

Registration Date:

03-28-2023

Goods and Services:

Clinical and laboratory research and testing, research testing of materials, namely, the use of genetically-engineered pigs, into which an adenoviral vector encoding Cre recombinase is induced, resulting in the formation of tumors in the target organ; research testing protocols conducting testing on tumors via drug or medical device, with subsequent collection of data, tissue samples, and/or images to assess the development and performance of cancer treatments, diagnostics, devices, and drugs

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Servicemark

Published for Opposition Date:

01-10-2023

Owner:

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

TAFT STETTINIUS & HOLLISTER

Correspondent Name:

Recent Trademark filings by this company